RBC Capital Markets analyst Bish Koziol made four changes to his Top 40 list of Canadian stocks. The selection method ...

Investing.com - Microsoft's first-quarter results and its current-quarter guidance have left many disappointed investors in ...

Gold futures fell 0.7% to $2,675.40 a troy ounce early Monday. Gold saw a sharp selloff after Donald Trump's victory in the U.S. presidential election, and is down 2.6% on week. That said, gold looks ...

Following the company’s second quarter results, RBC analyst Sabahat Khan has trimmed his price target on ATS Corp.

RBC's second-quarter fiscal 2025 adjusted earnings ... When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd ...

Donald Trump will return to the White House and will bring major changes to the country's tax, AI and energy policies.

RBC Capital analyst Daniel Perlin maintained a Hold rating on DXC Technology (DXC – Research Report) today and set a price target of ...

Investing.com -- US equity positioning and valuations are looking increasingly stretched, according to RBC Capital Markets. "US equity positioning in the futures market – including S&P 500 contracts – ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

TipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including IBM and Ares Capital.

On Tuesday, RBC Capital Markets adjusted its outlook on shares of Adverum Biotechnologies (NASDAQ:ADVM), decreasing the price target to $10.00 from the previous $12.00, while maintaining a Sector ...